You Wu

1.3k total citations · 1 hit paper
31 papers, 892 citations indexed

About

You Wu is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, You Wu has authored 31 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in You Wu's work include Lipoproteins and Cardiovascular Health (12 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer, Lipids, and Metabolism (4 papers). You Wu is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer, Lipids, and Metabolism (4 papers). You Wu collaborates with scholars based in United States, China and Switzerland. You Wu's co-authors include J. Antonio G. López, Huei Wang, Marc S. Sabatine, Helina Kassahun, Michelle L. O’Donoghue, Beat Knüsel, Bariş Gencer, Paul D. Wagner, R A North and Michael Forte and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

In The Last Decade

You Wu

29 papers receiving 877 citations

Hit Papers

Small Interfering RNA to Reduce Lipoprotein(a) in Cardiov... 2022 2026 2023 2024 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
You Wu United States 15 448 238 174 168 135 31 892
Alanna Strong United States 13 303 0.7× 721 3.0× 229 1.3× 88 0.5× 111 0.8× 47 1.3k
Li-Xin Shan United States 11 262 0.6× 386 1.6× 23 0.1× 167 1.0× 66 0.5× 17 1.1k
Anitra C. Wolf United States 10 282 0.6× 137 0.6× 76 0.4× 307 1.8× 141 1.0× 13 536
Diane R. Olson United States 10 239 0.5× 1.0k 4.4× 68 0.4× 279 1.7× 34 0.3× 11 1.2k
S. Matsushima Japan 13 99 0.2× 298 1.3× 107 0.6× 20 0.1× 51 0.4× 31 802
Fruzsina Kotsis Germany 17 90 0.2× 817 3.4× 46 0.3× 57 0.3× 107 0.8× 37 1.3k
Anh Diep United States 19 133 0.3× 438 1.8× 31 0.2× 95 0.6× 170 1.3× 32 1.0k
Yuan-Yuan Ho Hong Kong 12 83 0.2× 325 1.4× 64 0.4× 59 0.4× 86 0.6× 18 785
Victoria South United States 5 189 0.4× 263 1.1× 220 1.3× 290 1.7× 70 0.5× 8 655
Judith Magenheim Israel 15 544 1.2× 704 3.0× 38 0.2× 182 1.1× 202 1.5× 24 1.3k

Countries citing papers authored by You Wu

Since Specialization
Citations

This map shows the geographic impact of You Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by You Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites You Wu more than expected).

Fields of papers citing papers by You Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by You Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by You Wu. The network helps show where You Wu may publish in the future.

Co-authorship network of co-authors of You Wu

This figure shows the co-authorship network connecting the top 25 collaborators of You Wu. A scholar is included among the top collaborators of You Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with You Wu. You Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosenson, Robert S., J. Antonio G. López, Daniel Gaudet, et al.. (2025). Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers. JAMA Cardiology. 10(5). 482–482. 13 indexed citations
2.
Gaba, Prakriti, Robert S. Rosenson, J. Antonio G. López, et al.. (2024). Intraindividual Variability in Serial Lipoprotein(a) Concentrations Among Placebo-Treated Patients in the OCEAN(a)-DOSE Trial. Journal of the American College of Cardiology. 85(5). 550–553. 10 indexed citations
3.
O’Donoghue, Michelle L., Robert S. Rosenson, J. Antonio G. López, et al.. (2024). The Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering. Journal of the American College of Cardiology. 84(9). 790–797. 27 indexed citations
4.
Wu, You, et al.. (2024). EP.12B.02 Real-World Treatment Patterns and Effectiveness in Patients with ALK+ Advanced NSCLC Treated with 1L ALK TKIs. Journal of Thoracic Oncology. 19(10). S641–S641. 1 indexed citations
5.
Tan, Hong Kee, Weimin Li, Zhouqing Huang, et al.. (2023). Efficacy and Safety of Evolocumab in Chinese Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia: 12-Week Primary Results of the HUA TUO 华佗 Randomized Clinical Trial. Cardiology and Therapy. 12(2). 341–359. 4 indexed citations
6.
Gaba, Prakriti, Michelle L. O’Donoghue, J. Antonio G. López, et al.. (2023). Abstract 12103: Intraindividual Variability in Serial Lipoprotein(a) Concentration Among Placebo-Treated Patients in the OCEAN(a)-DOSE Trial. Circulation. 148(Suppl_1). 5 indexed citations
7.
Rosenson, Robert S., J. Antonio G. López, Maria Laura Monsalvo, et al.. (2022). Quantification of LDL-Cholesterol Corrected for Molar Concentration of Lipoprotein(a). Cardiovascular Drugs and Therapy. 38(1). 191–197. 12 indexed citations
9.
O’Donoghue, Michelle L., J. Antonio G. López, Beat Knüsel, et al.. (2022). Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE). American Heart Journal. 251. 61–69. 76 indexed citations
10.
Bansal, Sandeep, Andrea Ruzza, Vimal Mehta, et al.. (2021). Evolocumab in patients with homozygous familial hypercholesterolemia in India. Journal of clinical lipidology. 15(6). 814–821. 16 indexed citations
11.
Yin, Cong, Zihan Li, Ping Yang, et al.. (2021). Effect of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis. Frontiers in Nutrition. 8. 709683–709683. 58 indexed citations
12.
Wu, You, Susmita Datta, Bertis B. Little, & Maiying Kong. (2020). Magnesium dietary intake and physical activity in Type 2 diabetes by gender in White, African‐American and Mexican American: NHANES 2011‐2014. Endocrinology Diabetes & Metabolism. 4(1). e00203–e00203. 3 indexed citations
14.
Wu, You, F.O. Hoffman, A. Iulian Apostoaei, et al.. (2019). Methods to account for uncertainties in exposure assessment in studies of environmental exposures. Environmental Health. 18(1). 31–31. 24 indexed citations
15.
Mei, Henrik E., Yanqin Hu, Tingting Guo, et al.. (2019). S826 IMPROVED EFFICACY AND SAFETY OF A DUAL‐TARGET CAR‐T CELL THERAPY TARGETING BCMA AND CD38 FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM A PHASE I STUDY. HemaSphere. 3(S1). 365–366. 10 indexed citations
16.
Song, Guohua, Xia Wu, Pu Zhang, et al.. (2016). High-density lipoprotein inhibits ox-LDL-induced adipokine secretion by upregulating SR-BI expression and suppressing ER Stress pathway. Scientific Reports. 6(1). 30889–30889. 22 indexed citations
17.
Rubin, Donald B. & You Wu. (1997). Modeling Schizophrenic Behavior Using General Mixture Components. Biometrics. 53(1). 243–243. 21 indexed citations
18.
Wu, You & Paul D. Wagner. (1991). Effects of phosphatase inhibitors and a protein phosphatase on norepinephrine secretion by permeabilized bovine chromaffin cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1092(3). 384–390. 18 indexed citations
19.
Kavanaugh, Michael P., MacDonald J. Christie, Peregrine B. Osborne, et al.. (1991). Transmitter regulation of voltage-dependent K+ channels expressed in Xenopus oocytes. Biochemical Journal. 277(3). 899–902. 16 indexed citations
20.
Wu, You & Paul D. Wagner. (1991). Calpactin‐depleted cytosolic proteins restore Ca2+‐dependent secretion to digitonin‐permeabilized bovine chromaffin cells. FEBS Letters. 282(1). 197–199. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026